Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy

Non-ischemic dilated cardiomyopathy encompasses a wide spectrum of myocardial disorders, characterized by left ventricular dilatation with systolic impairment and increased risk of sudden cardiac death. In spite of all the therapeutic progress that has been made in recent years, dilated cardiomyopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Anghel, Larisa, Sascău, Radu, Zota, Ioana Mădălina, Stătescu, Cristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198011/
https://www.ncbi.nlm.nih.gov/pubmed/34073616
http://dx.doi.org/10.3390/ijms22115688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198011/
https://www.ncbi.nlm.nih.gov/pubmed/34073616
http://dx.doi.org/10.3390/ijms22115688

Ejemplares similares